Multi-omic signature of body weight change: Results from a population-based cohort study

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Wahl, Simone ^a,b   Vogt, Susanne ^a   Stückler, Ferdinand ^a   Krumsiek, Jan ^a   Bartel, Jörg ^a   Kacprowski, Tim ^c   Schramm, Katharina ^a,d   Carstensen, Maren ^b,e   Rathmann, Wolfgang ^e   Roden, Michael ^b,e,f   Jourdan, Carolin ^a   Kangas, Antti J ^g   Soininen, Pasi ^g,h   Ala Korpela, Mika ^g,h,i,j   Nöthlings, Ute ^k   Boeing, Heiner ^l   Theis, Fabian J ^a,d   Meisinger, Christa ^a   Waldenberger, Melanie ^a   Suhre, Karsten ^a,m   Homuth, Georg ^c   Gieger, Christian ^a   Kastenmüller, Gabi ^a   Illig, Thomas ^a,n   Linseisen, Jakob ^a   Peters, Annette ^a,b,o   Prokisch, Holger ^a,d   Herder, Christian ^b,e   Thorand, Barbara ^a,b   Grallert, Harald ^a,b   more..

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^f UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^g UNIVERSITY OF OULU   (Finland)

^h UNIVERSITY OF EASTERN FINLAND   (Finland)

ⁱ OULU UNIVERSITY HOSPITAL   (Finland)

^j UNIVERSITY OF BRISTOL   (United Kingdom)

^k UNIVERSITY OF BONN   (Germany)

^l GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^m WEILL CORNELL MEDICAL COLLEGE   (Qatar)

ⁿ HANNOVER MEDICAL SCHOOL   (Germany)

^o Deutsches Forschungszentrum für Herz Kreislauferkrankungen   (Germany)

more..

Author keywords

Bioinformatics; Metabolomics; Molecular epidemiology; Obesity; Transcriptomics; Weight change

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHOLIPID TRANSFER PROTEIN; S6 KINASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AMINO ACID METABOLISM; ARTICLE; ATHEROSCLEROSIS; BIOGENESIS; BODY WEIGHT; CARDIOMETABOLIC RISK; CELL MATURATION; COHORT ANALYSIS; CONTROLLED STUDY; ENERGY METABOLISM; FATTY ACID OXIDATION; FEMALE; GENE EXPRESSION; HUMAN; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; MASS SPECTROMETRY; MEDICAL RESEARCH; METABOLOMICS; MOLECULAR EPIDEMIOLOGY; OBESITY; PARTICLE SIZE; POPULATION RESEARCH; PROSPECTIVE STUDY; RISK FACTOR; RNA ISOLATION; SENSITIVITY ANALYSIS; TRANSCRIPTOMICS; UPREGULATION; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; CROSS-SECTIONAL STUDY; GENE REGULATORY NETWORK; METABOLOME; MIDDLE AGED; PHYSIOLOGY; STATISTICAL MODEL;

ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION; GENE REGULATORY NETWORKS; HUMANS; LINEAR MODELS; METABOLOME; METABOLOMICS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; WEIGHT GAIN;

EID: 84928266005     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0282-y     Document Type: Article

References (70)

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766-81.
2. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.
3. Cornelis MC, Hu FB. Systems epidemiology: a new direction in nutrition and metabolic disease research. Curr Nutr Rep. 2013;2:225-35.
4. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311-26.
5. Oberbach A, Bluher M, Wirth H, Till H, Kovacs P, Kullnick Y, et al. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res. 2011;10:4769-88.
6. Wahl S, Yu Z, Kleber M, Singmann P, Holzapfel C, He Y, et al. Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts. 2012;5:660-70.
7. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J, et al. Genetics of gene expression and its effect on disease. Nature. 2008;452:423-8.
8. Ghosh S, Dent R, Harper ME, Gorman SA, Stuart JS, McPherson R. Gene expression profiling in whole blood identifies distinct biological pathways associated with obesity. BMC Med Genomics. 2010;3:56.
9. Pietilainen KH, Naukkarinen J, Rissanen A, Saharinen J, Ellonen P, Keranen H, et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med. 2008;5:e51.
10. Reinehr T, Wolters B, Knop C, Lass N, Hellmuth C, Harder U, et al. Changes in the serum metabolite profile in obese children with weight loss. Eur J Nutr. In press.
11. Naganuma R, Sakurai M, Miura K, Yoshita K, Morikawa Y, Kido T, et al. Relation of long-term body weight change to change in lipoprotein particle size in Japanese men and women: the INTERMAP Toyama Study. Atherosclerosis. 2009;206:282-6.
12. Mantyselka P, Kautiainen H, Saltevo J, Wurtz P, Soininen P, Kangas AJ, et al. Weight change and lipoprotein particle concentration and particle size: a cohort study with 6.5-year follow-up. Atherosclerosis. 2012;223:239-43.
13. Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, Kumpula LS, et al. Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol. 2010;6:441.
14. Zhou M, Wang S, Zhao A, Wang K, Fan Z, Yang H, et al. Transcriptomic and metabonomic profiling reveal synergistic effects of quercetin and resveratrol supplementation in high fat diet fed mice. J Proteome Res. 2012;11:4961-71.
15. Xu T, Holzapfel C, Dong X, Bader E, Yu Z, Prehn C, et al. Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med. 2013;11:60.
16. Holle R, Happich M, Lowel H, Wichmann HE, MONICA KORA Study Group: KORA--a research platform for population based health research. Gesundheitswesen. 2005; Suppl 1:19-25.
17. Wolfenstetter SB, Menn P, Holle R, Mielck A, Meisinger C, von Lengerke T. Body. weight changes and outpatient medical care utilisation: results of the MONICA/KORA cohorts S3/F3 and S4/F4. Psychosoc Med. 2012;9:Doc09. doi:10.3205/psm000087.
18. Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003;46:182-9.
19. Mühlberger N, Behrend C, Stark R, Holle R. Datenbankgestützte Online-Erfassung von Arzneimitteln im Rahmen gesundheitswissenschaftlicher Studien - Erfahrungen mit der IDOM-Software. Informatik, Biometrie und Epidemiologie in Medizin und Biologie. 2003;34:601-11.
20. DeHaven CD, Evans AM, Dai H, Lawton KA. Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform. 2010;2:9.
21. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81:6656-67.
22. Soininen P, Kangas AJ, Wurtz P, Tukiainen T, Tynkkynen T, Laatikainen R, et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 2009;134:1781-5.
23. Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet. 2008;40:430-6.
24. Schurmann C, Heim K, Schillert A, Blankenberg S, Carstensen M, Dorr M, et al. Analyzing illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the metaxpress consortium. PLoS One. 2012;7:e50938.
25. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2014. http://www.R-project.org .
26. Bioconductor: Open Source Software for Bioinformatics. http://www.bioconductor.org .
27. van Buuren S, Groothuis-Oudshoorn K. mice:. Multivariate Imputation by Chained Equations in R. J Stat Softw. 2011;45:1-67.
28. Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Syst Biol. 2007;3:140.
29. Inouye M, Ripatti S, Kettunen J, Lyytikainen LP, Oksala N, Laurila PP, et al. Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet. 2012;8:e1002907.
30. Zhang B, Horvath S. A. general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article 17. Epub 2005 Aug 12.
31. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
32. Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics. 2008;24:719-20.
33. Krumsiek J, Suhre K, Illig T, Adamski J, Theis FJ. Bayesian independent component analysis recovers pathway signatures from blood metabolomics data. J Proteome Res. 2012;11:4120-31.
34. Wahl S, Krug S, Then C, Kirchhofer A, Kastenmüller G, Brand T, et al. Comparative analysis of plasma metabolomics response to metabolic challenge tests in healthy subjects and influence of the FTO obesity risk allele. Metabolomics. 2013;10:386-401.
35. Ingenuity. http://www.ingenuity.com .
36. Krumsiek J, Suhre K, Illig T, Adamski J, Theis FJ. Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data. BMC Syst Biol. 2011;5:21.
37. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5:1218-40.
38. Brunzell J, Hokanson J. Dyslipidemia of central obesity and insulin resistance. Diabetes Care. 1999;22:C10-3.
39. Tzotzas T, Desrumaux C, Lagrost L. Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor. Obes Rev. 2009;10:403-11.
40. Tukiainen T, Kettunen J, Kangas AJ, Lyytikainen LP, Soininen P, Sarin AP, et al. Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci. Hum Mol Genet. 2012;21:1444-55.
41. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:1046-53.
42. Musunuru K, Orho-Melander M, Caulfield MP, Li S, Salameh WA, Reitz RE, et al. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol. 2009;29:1975-80.
43. Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, Ridker PM. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes. 2010;59:1153-60.
44. Felig P, Marliss E, Cahill GJ. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med. 1969;281:811-6.
45. Lu J, Xie G, Jia W, Jia W. Insulin resistance and the metabolism of branched-chain amino acids. Front Med. 2013;7:53-9.
46. Wurtz P, Tiainen M, Makinen VP, Kangas AJ, Soininen P, Saltevo J, et al. Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care. 2012;35:1749-56.
47. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17:448-53.
48. Wiklund PK, Pekkala S, Autio R, Munukka E, Xu L, Saltevo J, et al. Serum metabolic profiles in overweight and obese women with and without metabolic syndrome. Diabetol Metab Syndr. 2014;6:40.
49. Demine S, Reddy N, Renard P, Raes M, Arnould T. Unraveling biochemical pathways affected by mitochondrial dysfunctions using metabolomic approaches. Metabolites. 2014;4:831-78.
50. Rogge MM. The role of impaired mitochondrial lipid oxidation in obesity. Biol Res Nurs. 2009;10:356-73.
51. Kelley D, He J, Menshikova E, Ritov V. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51:2944-50.
52. Keun HC, Sidhu J, Pchejetski D, Lewis JS, Marconell H, Patterson M, et al. Serum molecular signatures of weight change during early breast cancer chemotherapy. Clin Cancer Res. 2009;15:6716-23.
53. Mailloux R, Lemire J, Appanna V. Aluminum-induced mitochondrial dysfunction leads to lipid accumulation in human hepatocytes: a link to obesity. Cell Physiol Biochem. 2007;20:627-38.
54. Clarke C, Xiao R, Place E, Zhang Z, Sondheimer N, Bennett M, et al. Mitochondrial respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites. Mol Genet Metab. 2013;110:145-52.
55. Shaham O, Slate NG, Goldberger O, Xu Q, Ramanathan A, Souza AL, et al. A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc Natl Acad Sci U S A. 2010;107:1571-5.
56. Goh SH, Josleyn M, Lee YT, Danner RL, Gherman RB, Cam MC, et al. The human reticulocyte transcriptome. Physiol Genomics. 2007;30:172-8.
57. Trottier MD, Naaz A, Li Y, Fraker PJ. Enhancement of hematopoiesis and lymphopoiesis in diet-induced obese mice. Proc Natl Acad Sci U S A. 2012;109:7622-9.
58. Virtue M, Furne J, Nuttall F, Levitt M. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care. 2004;27:931-5.
59. Kendall RG, Mellors I, Hardy J, Mardle B. Patients with pulmonary and cardiac disease show an elevated proportion of immature reticulocytes. Clin Lab Haematol. 2001;23:27-31.
60. Joehanes R, Ying S, Huan T, Johnson AD, Raghavachari N, Wang R, et al. Gene expression signatures of coronary heart disease. Arterioscler Thromb Vasc Biol. 2013;33:1418-26.
61. Zhang Y, Ma AQ, Gong M, Lu Q, Lu M, Tian G. Red blood cell level is increased in obese but not in non-obese patients with coronary heart disease. J Geriatr Cardiol. 2010;7:143-6.
62. Inouye M, Silander K, Hamalainen E, Salomaa V, Harald K, Jousilahti P, et al. An immune response network associated with blood lipid levels. PLoS Genet. 2010;6:e1001113.
63. Sokol CL, Barton GM, Farr AG, Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol. 2008;9:310-8.
64. Imtiyaz HZ, Williams EP, Hickey MM, Patel SA, Durham AC, Yuan LJ, et al. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest. 2010;120:2699-714.
65. Zhang H, Zhang G, Gonzalez FJ, Park SM, Cai D. Hypoxia-inducible factor directs POMC gene to mediate hypothalamic glucose sensing and energy balance regulation. PLoS Biol. 2011;9:e1001112.
66. Gonen B, O'Donnell P, Post T, Quinn T, Schulman E. Very low density lipoproteins (VLDL) trigger the release of histamine from human basophils. Biochim Biophys Acta. 1987;917:418-24.
67. Shore SA. Obesity, airway hyperresponsiveness, and inflammation. J Appl Physiol. 2010;108:735-43.
68. Johansson LE, Danielsson AP, Parikh H, Klintenberg M, Norstrom F, Groop L, et al. Differential gene expression in adipose tissue from obese human subjects during weight loss and weight maintenance. Am J Clin Nutr. 2012;96:196-207.
69. Valcarcel B, Ebbels TM, Kangas AJ, Soininen P, Elliot P, Ala-Korpela M, et al. Genome metabolome integrated network analysis to uncover connections between genetic variants and complex traits: an application to obesity. J R Soc Interface. 2014;11:20130908.
70. Siri-Tarino PW, Williams PT, Fernstrom HS, Rawlings RS, Krauss RM. Reversal of small, dense LDL subclass phenotype by normalization of adiposity. Obesity. 2009;17:1768-75.